Related Experiment Video
Updated: Jul 7, 2026

In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells (iTregs) from Naïve CD4+ T Cells Using a TGF-β-containing Protocol
Published on: December 30, 2016
Cutting edge: TGF-beta-induced expression of Foxp3 in T cells is mediated through inactivation of ERK
Xunrong Luo1, Qiang Zhang, Victoria Liu
1Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Abstract:
The peripheral induction of T regulatory cells can be accomplished by TGF-beta through an epigenetic regulation leading to the expression of Foxp3. However, the exact mechanism of such a TGF-beta-mediated action remains unclear. In the current study, we found that TGF-beta treatment of CD4+CD25- T cells during T cell activation led to a transient inhibition of the phosphorylation of ERK followed by the induction of Foxp3 expression in these cells. Direct treatment with a specific ERK inhibitor, UO126, during CD4+CD25- T cell activation also induced Foxp3 expression and conferred a suppressive function to the induced Foxp3+ T cells. Furthermore, treatment of T cells with either TGF-beta or UO126 significantly down-regulated the expression of DNMTs, a reaction normally elicited by demethylation agents, such as 5-Aza-2'-deoxycytidine. These results indicate that the epigenetic regulation of TGF-beta-induced expression of Foxp3 may be mediated through the inactivation of ERK.
Insights
Transforming growth factor-beta (TGF-β) induces regulatory T cells via epigenetic changes. This study reveals that inhibiting ERK phosphorylation is key to TGF-β’s mechanism for Foxp3 expression and T cell regulation.
Area of Science:
- Immunology
- Epigenetics
- Cellular Biology
Background:
- Regulatory T cells (Tregs) are crucial for immune homeostasis.
- Transforming growth factor-beta (TGF-β) is known to induce T regulatory cells through epigenetic mechanisms.
- The precise molecular pathway of TGF-β-mediated Treg induction remains incompletely understood.
Purpose of the Study:
- To elucidate the mechanism by which TGF-β induces Foxp3 expression in T cells.
- To investigate the role of Extracellular signal-Regulated Kinase (ERK) signaling in TGF-β-driven epigenetic regulation.
- To determine if inhibiting ERK can replicate TGF-β's effects on T regulatory cell induction.
Main Methods:
- CD4+CD25- T cells were treated with TGF-β during activation.
- ERK phosphorylation was assessed following TGF-β treatment.
- T cells were activated in the presence of a specific ERK inhibitor (UO126).
- Expression of DNA methyltransferases (DNMTs) was analyzed after treatment with TGF-β or UO126.
Main Results:
- TGF-β treatment transiently inhibited ERK phosphorylation, followed by Foxp3 induction.
- Direct inhibition of ERK using UO126 also induced Foxp3 expression and suppressive function.
- Both TGF-β and UO126 treatments led to down-regulation of DNMTs.
- The observed DNMT down-regulation mimicked effects of demethylation agents.
Conclusions:
- Epigenetic regulation of Foxp3 expression by TGF-β is mediated through the inactivation of ERK signaling.
- ERK pathway inhibition is a critical step in TGF-β-induced T regulatory cell differentiation.
- Targeting the ERK pathway offers a potential strategy for modulating T regulatory cell populations.
Related Concept Videos
TGF - β Signaling Pathway
MAPK Signaling Cascades
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Regulation of Angiogenesis and Blood Supply
